RNU4ATAC9P

Across TCGA pan-cancer cohorts, RNU4ATAC9P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU4ATAC9P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RNU4ATAC9P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU4ATAC9P is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

THCA and BRCA are the cancer types where RNU4ATAC9P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU4ATAC9P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.927	<.001	8	view →
BRCA	Female	All	−0.244	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RNU4ATAC9P–THCA

Open the THCA breakdown →